Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 2
1998 1
1999 1
2000 2
2004 1
2007 1
2008 1
2009 3
2010 1
2011 4
2012 3
2013 2
2014 3
2015 3
2016 2
2017 3
2018 1
2019 1
2020 4
2021 5
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.
Coyne DW, Singh AK, Lopes RD, Bailey CK, DiMino TL, Huang C, Connaire J, Rastogi A, Kim SG, Orias M, Shah S, Patel V, Cobitz AR, Wanner C. Coyne DW, et al. Among authors: orias m. Clin J Am Soc Nephrol. 2022 Sep;17(9):1325-1336. doi: 10.2215/CJN.00550122. Epub 2022 Aug 2. Clin J Am Soc Nephrol. 2022. PMID: 35918106 Free PMC article. Clinical Trial.
Albuminuria and cardiovascular risk.
Rigo DH, Jiménez PM, Orias M. Rigo DH, et al. Among authors: orias m. Hipertens Riesgo Vasc. 2023 Jul-Sep;40(3):137-144. doi: 10.1016/j.hipert.2023.03.003. Epub 2023 Sep 23. Hipertens Riesgo Vasc. 2023. PMID: 37748947 Review.
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators. Pfeffer MA, et al. N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30. N Engl J Med. 2009. PMID: 19880844 Free article. Clinical Trial.
Is Isolated Diastolic Hypertension an Important Phenotype?
Romero CA, Tabares AH, Orias M. Romero CA, et al. Among authors: orias m. Curr Cardiol Rep. 2021 Oct 16;23(12):177. doi: 10.1007/s11886-021-01609-w. Curr Cardiol Rep. 2021. PMID: 34657205 Free PMC article. Review.
Global Dialysis Perspective: Argentina.
Orias M, Rosa Diez GJ. Orias M, et al. Kidney360. 2020 Apr 28;1(7):676-679. doi: 10.34067/KID.0001222019. eCollection 2020 Jul 30. Kidney360. 2020. PMID: 35372938 Free PMC article. No abstract available.
Hypertension and kidney disease progression.
Rigo D, Orias M. Rigo D, et al. Among authors: orias m. Clin Nephrol. 2020 Supplement-Jan;93(1):103-107. doi: 10.5414/CNP92S118. Clin Nephrol. 2020. PMID: 31549630
2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action.
Campbell NRC, Whelton PK, Orias M, Wainford RD, Cappuccio FP, Ide N, Neal B, Cohn J, Cobb LK, Webster J, Trieu K, He FJ, McLean RM, Blanco-Metzler A, Woodward M, Khan N, Kokubo Y, Nederveen L, Arcand J, MacGregor GA, Owolabi MO, Lisheng L, Parati G, Lackland DT, Charchar FJ, Williams B, Tomaszewski M, Romero CA, Champagne B, L'Abbe MR, Weber MA, Schlaich MP, Fogo A, Feigin VL, Akinyemi R, Inserra F, Menon B, Simas M, Neves MF, Hristova K, Pullen C, Pandeya S, Ge J, Jalil JE, Wang JG, Wideimsky J, Kreutz R, Wenzel U, Stowasser M, Arango M, Protogerou A, Gkaliagkousi E, Fuchs FD, Patil M, Chan AW, Nemcsik J, Tsuyuki RT, Narasingan SN, Sarrafzadegan N, Ramos ME, Yeo N, Rakugi H, Ramirez AJ, Álvarez G, Berbari A, Kim CI, Ihm SH, Chia YC, Unurjargal T, Park HK, Wahab K, McGuire H, Dashdorj NJ, Ishaq M, Ona DID, Mercado-Asis LB, Prejbisz A, Leenaerts M, Simão C, Pinto F, Almustafa BA, Spaak J, Farsky S, Lovic D, Zhang XH. Campbell NRC, et al. Among authors: orias m. J Hum Hypertens. 2023 Jun;37(6):428-437. doi: 10.1038/s41371-022-00690-0. Epub 2022 May 17. J Hum Hypertens. 2023. PMID: 35581323 Free PMC article. Review. No abstract available.
Does kidney disease cause hypertension?
Peixoto AJ, Orias M, Desir GV. Peixoto AJ, et al. Among authors: orias m. Curr Hypertens Rep. 2013 Apr;15(2):89-94. doi: 10.1007/s11906-013-0327-6. Curr Hypertens Rep. 2013. PMID: 23344662 Review.
53 results